Coronary artery disease patients
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1, Patients of 20 year of age or over 2, Patients who are candidates for DCA 3, Patients for whom written consent has been obtained by the individual
Exclusion criteria
Exclusion criteria: Patients taking steroids or undergoing treatment for cancer, or suffering from hepatitis B and C viruses Other patients who are deemed inappropriate by the physician in charge of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The existence of somatic mutation in blood and coronary culprit plaques | — |
Secondary
| Measure | Time frame |
|---|---|
| 1, The ratio of somatic mutation and the place in gene map of somatic mutation. 2, CT or MRI evaluation of coronary plaques 3, Histological evaluation 4, Single cell RNA and ATAC sequencing of blood and coronary culprit plaque samples 5, The interaction of somatic mutations and single cell RN and ATAC sequencing of blood and coronary culprit plaque samples. 6, Metabolomics in plasma | — |
Countries
Japan
Contacts
Kobe University School of Medicine Division of Cardiovascular Medicine, Department of Internal Medicine